Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

Completed · Phase 1

Conditions studied: Bacterial Infection

In brief

Pediatric study to evaluate the safety and pharmacokinetics of solithromycin (oral and intravenous) in children ages 0 to 17

Key facts

Study ID
NCT02268279
Run by
Melinta Therapeutics, Inc.
People needed
84
Starts
2015-01-01
Expected to finish
2016-10-01
Last updated by the study team
2017-06-09

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.